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The influence of health systems on breast, cervical and 
colorectal cancer screening: an overview of systematic 
reviews using health systems and implementation research 
frameworks 
 
Abstract  
Objectives:  Screening for breast, cervical and colorectal cancer in an average-risk population is 
widely recommended in national and international guidelines although their implementation varies. 
Using a conceptual framework that draws on implementation and health systems research, we 
provide an overview of systematic literature reviews that address health system and service barriers 
or facilitators to effective cancer screening.  
Methods:  Using a systematic approach, we searched Cochrane Database of Systematic Reviews, 
Ovid Medline, Ovid Embase, Web of Science, PsychInfo and other internet sources. We included 
systematic reviews of screening interventions (i.e. targeting people at average risk) for breast, 
cervical and colorectal cancer. The analysis included 90 systematic reviews.  
Results: This review identified a multitude of barriers and facilitators affecting the health system, the 
capabilities of individuals in the system and their intentions. A large proportion of the available 
evidence focused on uptake. The reviews demonstrated that health system factors influenced 
participation, as well as quality and effectiveness of the service provided. The barriers with the 
biggest impact were knowledge/education, mainly of clients but also providers (capability barriers) 
and beliefs and values (intention barriers) of the eligible population. These findings complement the 
usual focus on psychological and social barriers to informed participation by individuals that 
dominate the screening literature. The facilitators with the most supporting evidence were 
educational interventions (overcoming capability and intention barriers), invitation letters and 
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reminders and appointments. These were mainly directed at eligible individuals and, to a lesser 
extent, to providers and healthcare professionals. Only a small number of reviews, mainly from 
Europe, specified organised, rather than opportunistic, screening programmes. In those, low 
participation was the most frequently cited barrier and invitation letters (including physician 
endorsement, phone calls, and reminders to non-responders and healthcare professionals) were the 
most prevalent facilitators.  
Conclusion: Despite evidence of barriers and facilitators to screening participation and opportunistic 
screening, further health systems research covering the entire screening system for organised 
programmes is required. 
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Introduction  
 
The European Union recommends population-based screening programmes for breast, cervical and 
colorectal cancer(1), while various guidelines set out how to implement such programmes(2-6). 
However, implementation varies greatly(7) and many programmes fall short of the ideal(8, 9). While 
much research examines the characteristics of individuals undergoing screening, there is, to our 
knowledge, much less focus on the characteristics of health systems that support or inhibit effective 
screening programmes.  
In this article we report the findings from an umbrella review of existing systematic reviews seeking 
to identify barriers and facilitators to population-based screening that are related to characteristics 
of health systems. We use the World Health Organisation’s (WHO) definition of health systems as 
consisting of ‘all organizations, people and actions whose primary intent is to promote, restore or 
maintain health’ (10). Firstly, we identify barriers that have been reported in the literature and, 
where possible, assess their impact.  Secondly, we identify measures that have been suggested to 
overcome these barriers and, where possible, assess their effectiveness.  Thirdly, we seek to 
understand the influence that these barriers and facilitators have on organised screening 
programmes. We use frameworks(11) that  draw on theories from behaviour change(12) and 
implementation research,(13) including those used by Michie et al.(14) who propose 12 subthemes 
for investigating implementation of evidence-based practice, organized within three main themes. 
Health system barriers include availability of resources, affordability, and acceptability of health 
services. Capability barriers relate to knowledge or skills to implement effective screening 
programmes. Intention barriers relate to motivations of providers to achieve effective screening. 
When looking at health systems barriers we draw on two related frameworks. The first was used in 
previous systematic reviews of barriers and facilitators to effective hypertension management(11, 
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15) and considers the contribution of health system inputs, including physical, human, intellectual 
and social resources, on outcomes. The second is the WHO’s health systems building blocks, with 
service delivery, the health workforce, health information systems, leadership and governance, and 
financing most relevant to screening(16). However, in practice, many of the barriers we identify 
involve a combination of elements, for example where locations are underserved by facilities, it 
reflects both weaknesses in service delivery and inability to recruit and retain staff. 
Objectives 
 
We reviewed systematic literature reviews that identify, explore and evaluate barriers and 
facilitators to establishing effective cancer screening programmes at health system and health 
service level. We sought to identify gaps and make recommendations for future research. Individual 
cultural, psychological and social obstacles to informed participation lay outside the scope of this 
review. 
Methods 
 
A protocol was registered ‘a priori’ on PROSPERO, the international prospective register of 
systematic reviews(17).  
Search strategy and selection 
 
We searched for relevant systematic reviews in the following databases: Cochrane Database of 
Systematic Reviews; Ovid Medline; Ovid Embase; Web of Science; PsychInfo; and Google Scholar. 
We reviewed project websites (for example, Evidence for Policy and Practice Information Centre; 
Health Systems Evidence; Health Evidence Network; Agency for Healthcare Research and Quality) 
and contacted experts participating in the EU-TOPIA (TOwards imProved screening for breast, 
 5 
 
cervical and colorectal cancer In All of Europe) project(18), of which this research forms a part, to 
identify relevant grey literature. Reference lists of publications retrieved were manually searched. 
Selected databases were searched from 1st January 2000 to 9th June 2017 using relevant search 
terms (Appendix 1, online supplement).  Two reviewers independently assessed the titles and 
abstracts of the identified publications according to pre-defined inclusion criteria (Appendix 2, online 
supplement) and differences were resolved by discussion.  
Data collection and analysis 
 
Data from included systematic reviews were extracted using a predefined data extraction sheet. 
Fields included: authors; year of publication; objectives; selection criteria; information about barriers 
and facilitators; and impact on the effectiveness of screening. Authors were contacted where full 
texts were not available (only one responded). Data were extracted by one reviewer and checked by 
a second reviewer who extracted data on study design and applied the AMSTAR (A MeaSurement 
Tool to Assess systematic Reviews). Reviews were not excluded from data extraction on grounds of 
quality.  
A narrative synthesis using the conceptual framework (Figure 1) was conducted. The heterogeneous 
nature of the included data precluded quantitative synthesis or formal assessment of publication 
bias. We collated the data for all cancer sites together but noted where items were relevant to only 
one cancer site. We analysed differences between organised screening programmes and other 
screening interventions.  
 
Results 
Study characteristics and quality 
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From 536 identified titles, 90 articles were included in the review (Figure 2). As summarised in Table 
1, of the 90 included articles, 75 were in English and 15 had abstracts available in English. A summary 
of the characteristics of the included systematic reviews is presented in Appendix 3 (online 
supplement) and a list of excluded reviews is reported in Appendix 4 (online supplement). A 
summary of the quality of the included systematic reviews, assessed using the AMSTAR instrument, 
is presented in supporting information Appendix 5 (online supplement). Whilst generally of good 
quality, included reviews used slightly different reporting criteria to those in the AMSTAR checklist, 
for quantitative meta-analysis studies and controlled trials.  
Drawing on the first conceptual framework, as shown in Figure 3, we found that whilst health system 
resources, financing and delivery were mentioned in some included systematic reviews, the vast 
majority were interested in ‘other factors’ that acted as barriers or facilitators to screening, most 
notably the target population’s health knowledge, the effectiveness of appointment reminders, 
personal and cultural beliefs, and physician recommendations.  
In the following sections, the second framework allows us to describe the barriers and ways to 
overcome those barriers in more detail using the health system, capability and intention categories, 
and their sub-categories, described in Figure 4. 
Barriers to effective screening 
 
Health system barriers 
 
Much of the literature addresses barriers that reduce uptake of screening. These can be 
geographical, temporal, procedural, financial, or related to perceived quality.  
Geographical barriers to services and facilities are especially important, but not exclusively so, for 
those in remote areas. Screening facilities were sometimes in inconvenient locations(A1-A3), 
involving long travel distances(A2-A4), and posing transportation difficulties(A1, A2, A5-A8). 
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Temporal barriers include inconvenient appointment times(A2, A5, A9), long waits before 
appointments were available(A1, A5), unsuitable appointment times(A3, A10), and waiting room 
delays(A5, A11). Delay in receiving results may reduce participation in subsequent screening or 
intervention rounds (A5, A12). Procedural barriers relate to problems sending screening 
invitations(A1, A2), limited access to primary care(A11, A13), and a variety of organisational 
barriers(A4, A10, A13-A15) including cumbersome administrative processes(A12,A16). Financial 
barriers featured in many systematic reviews, especially where many in the target population lacked 
health insurance or other forms of coverage(A6, A9, A11, A13, A17-A20) or among those whose 
insurance excludes coverage of screening(A1, A2, A6, A7, A11, A13, A14, A17, A21, A22). Some 
reviews also identified financial constraints affecting providers(A4, A11, A13, A23, A24), including 
the cost of screening tests(A1, A2, A7, A9, A11, A15), which have implications for the ability to 
deliver services – for example where constraints affect the ability to recruit and retain staff.  
Perceptions of quality also matter(A1, A25), indicated by objective measures of screening test 
performance(A1) or subjective patient experiences(A1, A3, A25).  
Only two reviews considered inappropriate screening due to overuse(A26, A27), which is most often 
associated with opportunistic screening, although several reviews did highlight features of health 
systems that made it difficult to implement organised population-based screening programmes in 
place of opportunistic screening (A18, A28-A31). 
In general, these reviews did not take a health systems perspective – in other words, they did not 
seek explanations for the reported barriers in the design of the health systems in which they were 
embedded. However, the findings do suggest weaknesses in relation to all the inputs to health 
systems and their building blocks, in particular leadership and governance, but also service delivery, 
workforce, and information systems.  
Capability barriers 
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Only a few reviews examined the knowledge of health care providers(A11, A13, A32). Instead, most 
of the available evidence related to the capability of those being screened, with many studies 
identifying lack of awareness of either the rationale for screening or how to be screened(A2, A4, A8, 
A9, A11, A13, A15, A17, A27, A32-35).  
 
Intention barriers  
 
Multiple reviews identified a failure by providers to recommend screening(A2, A4, A8, A9, A11-13, 
A17, A19). Some described this as negligence(A32), while others attributed it to a lack of awareness 
of the need for screening(A1, A2), particularly for older adults, suggesting an implicit ageism(A21). 
Several pointed to inadequate communication between clinicians, providers and eligible 
individuals(A4, A11, A15, A18) but also, and arguably of greater concern, the spread of 
misinformation among the lay public(A1). These findings, and those relating to capabilities, point to 
weaknesses in leadership and governance, in particular poor recognition of the need to understand 
public knowledge and perceptions and to put in place measures to address knowledge gaps and 
misconceptions. 
Whilst this umbrella review explicitly excluded non-health system barriers specific to individuals or 
particular subgroups and cultures – for example barriers related to knowledge, attitudes and 
practices among a target population –   it was notable that these issues dominated many of the 
included reviews. These factors affecting informed participation, or intention to participate, are 
therefore summarised in the online supplementary information (Appendix 6). These factors also 
have implications for the leadership and governance of health systems, highlighting the requirement 
to put in place systems to identify unmet need and facilitate equitable uptake.  
The impact of health system barriers versus other barriers 
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Assessing the impact of barriers was challenging as most of the included systematic reviews 
reporting barriers (24 of 36 reviews) included studies using a variety of methods, not all of which 
could quantify impact. Those that focused on particular study designs included qualitative (4 
reviews), observational (1 review), quantitative (3 reviews), and interventional studies (including 
randomised controlled trials (RCT) and comparative studies) (4 reviews). Hence, quantitative 
syntheses evaluating the impact of barriers were limited. Only the review of observational studies 
calculated effect sizes for different factors affecting compliance(A32).  
Of the seven reviews including quantitative and interventional studies, only one described the most 
frequently cited barriers,(A21) while another counted the number of studies showing significant 
association between specific factors and screening uptake(A36).   
Ten of the reviews that included mixed study designs reported the number identifying each barrier, 
a very indirect measure of importance. Otherwise, the importance of barriers can only be inferred 
from the narrative syntheses of results of included studies and author conclusions (see 
Supplementary Information).  
Once again, most of the reviews focused on the consequences of weaknesses in screening 
programmes rather than causes related to the health system. Thus, many reviews sought  to 
understand and provide reasons for non-participation, including in specific population groups 
(Korean Americans, Hmong Americans, African Americans, Arabic women, Latinas) or in particular 
countries (Asia, Africa). In general, the barriers identified as most important in the narrative reviews 
reflect those with most supporting evidence (Figure 3), with most attention paid to characteristics of 
the target population rather than the system itself. Thus, the most important barriers identified 
were knowledge/education (capability barriers), and beliefs and values (intention barriers) of the 
population. Next in importance were financing/access barriers, including characteristics of the 
health workforce (training and knowledge). Service delivery barriers (infrastructure and supplies) 
were cited to a lesser extent.  
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These findings point to a failure of much of the literature on screening to look upstream at the 
health system characteristics that contribute to uptake by the target population or to use a health 
systems frameworks to analyse or interpret findings.  
Ways to overcome barriers 
 
Health system facilitators 
 
Some of the most frequently cited interventions evaluated as means to overcome health system 
barriers involved specific practical measures rather than wider changes to health systems (such 
wider changes might include new financing models, professional roles, or settings for service 
delivery). Thus, many examined measures to improve screening invitations(A37-A39), with the aim 
of increasing uptake(A1, A2, A5, A9). Examples included having letters(A37-A39) endorsed by a 
physician(A7, A40-A42), personalised(A7, A43), accompanied by a phone call(A37), or linked to 
special events promoting screening(A44). In addition, reminder letters and follow-up phone calls to 
those invited(A10, A16, A18, A23, A28, A30, A37, A40-A42, A45-A49) and reminders to 
physicians(A40, A47, A50-A53) were also frequently mentioned as facilitators. These reminders 
could be computer-generated(A50), part of a recall system(A16), chart-based(A53), or paper-based 
(requiring responses)(A50).  
Some interventions that did take a health system approach addressed the service delivery building 
block. Examples included: seeking to reduce geographic barriers to screening (including reducing 
distance needed to travel and increasing the number of facilities per person or in an area)(A54); 
providing assistance with transportation(A7, A10, A55) or free transport(A42); organising clinic-
based outreach services to deliver screening nearer areas with low participation(A56); offering 
alternative screening sites(A10); or introducing mobile screening units(A57, A58). Other aspects of 
service delivery examined included procedures. Improvements in this regard included having 
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scheduled appointment times (as opposed to open appointments, where the onus is on the recipient 
of the invitation to make their own appointment)(A41), flexible appointment times (for example, 
offering an option to change to out-of-hours or to meet individual needs)(A12, A46), more 
convenient out-of-hours appointments(A10), measures to decrease waiting times(A1, A25) and 
assistance for individuals to help schedule appointments(A45, A55, A58).  
A few interventions addressed the health workforce, for example, employing staff of the same 
gender or minority group(A3-A5, A20). Others transferred roles to the person being screened, for 
example with self-sampling by post(A31, A40, A41, A48, A59-A61) where technically possible (for 
example, colon and cervical self-sampling). 
Two interventions addressed health system financing, in terms of increasing insurance 
coverage(A17, A55). However, most that sought to overcome financial barriers looked at more 
targeted approaches,(A16, A32, A53, A62) including providing monetary incentives(A10, A30) or 
vouchers, or otherwise reducing out-of-pocket costs(A1, A7, A10, A47, A48, A57). 
Human resource strategies featured in a few reviews, including task shifting, using nurse 
specialists(A10, A12, A30, A47, A49, A63, A64), screening in the community setting (lay or outreach 
workers)(A28, A42, A49, A56, A58, A65) and involving primary care workers (A8, A39, A43, A45, 
A51). The concepts of ‘patient navigation’(A29, A42, A45, A52, A55) and aiding patients to make 
informed decisions(A84-A86) were evaluated in several reviews.  
Capability facilitators 
 
Some studies considered methods for facilitating improvement in provider capabilities. Ways of 
overcoming knowledge and skill barriers among providers included cascading of guidelines(A69), 
education and training(A31, A58), and measures to increase the extent to which providers 
recommend screening(A8, A24, A32, A42, A70, A71). A few studies examined measures to enhance 
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the quality of screening, including improved training of those conducting screening tests(A1, A10, 
A12, A25), double reading of samples(A72, A73), audit and feedback(A47). 
However, most reviews focused on measures to improve uptake by those in target populations(A29, 
A56, A74), such as: one-to-one education(A10, A16, A23, A42, A48); mailed educational 
material(A18, A31, A37, A42); face-to-face or phone communication(A29, A31, A33, A52, A66, A74-
A76); counselling(A18, A31, A38, A42, A63, A66, A67, A75-A77); education delivered by lay health 
workers(A31, A42, A57, A75, A76); multi-media information(A47, A66, A67, A76); print material(A67, 
A76); in-clinic education(A31); audio education materials (A67); personalised materials(A7, A29, 
A33); tailored information(A66, A76); small group education(A10, A16, A42, A48, A77); community-
based education(A28, A58, A66); education delivered by media(A28, A42); targeted media(A10, A16, 
A23, A77); and mass media(A10, A16, A56).  
Intention facilitators 
 
Measures to motivate providers inevitably addressed the health workforce building block. Examples 
included improving communication between primary care and other care providers(A5) and better 
mechanisms to enable coordination among clinicians, public health, cultural and religious 
organisations, advocacy and community groups(A78). As one study noted, the time and cost 
constraints involved in such measures need to be recognised(A32).  
Again, however, most measures to improve motivation were focused on the target populations, 
including the linguistic(A45, A55), cultural(A47, A49, A53, A55, A58, A1, A12), socioeconomic(A62), 
cognitive(A49) and other characteristics(A33, A53 , A62) of individuals.  
Effectiveness of interventions to overcome barriers 
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The systematic reviews reporting facilitators included studies with a range of methodologies but  
few summarised quantitative data or sought to establish causality. Forty one reviews provided some 
kind of synthesis, of which 14 presented the number of studies reporting a positive effect. The lack 
of standardisation across the reviews – regarding the interventions tested, reported outcomes, 
different characteristics of the target populations, and differences in the health care organization  – 
limited the synthesis of results. There is also likely to be overlap between the reviews of similar 
interventions, even though each of the systematic reviews analysed and reported the results 
differently. Some reviews reported factors positively influencing screening uptake without 
measuring effectiveness(A4, A36, A55, A78, A79). 
As shown in Figure 3, much of the available evidence (focusing on systematic reviews that provide a 
collated summary of results rather than a report of individual studies) measuring impact on 
effectiveness relates to one of three measures, each directed at individuals in the target 
populations. These are educational interventions (overcoming capability and intention barriers)(A23, 
A29, A30, A36-A38, A44, A45, A48, A49, A56, A57, A66-A68, A74, A80-A83), invitation letters and 
reminders(A16, A18, A23, A29, A30, A36-A41, A43, A48, A49, A80, A81) (to a lesser extent, to 
providers and healthcare professionals(A36, A50, A51)) and measures to improve access to 
appointments (enabling access to the health system)(A41).  
The evidence is generally supportive of educational measures(A8, A29, A30, A38, A52), particularly 
of education delivered via one-to-one sessions(A18, A23, A29, A48, A74, A81), peers, lay health 
workers(A49, A56, A57) or community interventions(A56, A65, A66, A84), telephone(A29, A36, A66, 
A74), decision aids(A52, A67, A68, A83), small media(A16, A23, A81), and mail(A37, A60, A66), 
although there are some other areas that require further investigation(A8, A36, A38). Multi-faceted 
interventions also found support(A29, A49, A57, A80). There is less evidence (either single reviews or 
mixed results) to support multi-media(A36, A66), mass media(A74, A81), special events(A44), 
mailed/printed materials(A36, A74), patient navigation(A45), personalised risk communication(A36, 
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A82) or stage-based promotion(A85), home visits(A36), tailored(A29) and group education(A48, 
A81). 
The evidence is positively supportive of invitation letters(A36-A39), including those with general 
practitioner involvement(A39, A41)(except cervical(A40) or multiple screening examinations(A37)) 
and/or personalised letters(A43) or telephone invitation(A36, A37), client reminders(A16, A18, A23, 
A30, A36, A37, A40, A41, A48, A49, A81), telephone reminders(A40, A41, A49) and physician 
reminders(A36, A40, A50, A51). Scheduled appointments(A36, A41) and self-sampling/mailed 
outreach are effective(A40, A41, A59, A60, A86). In contrast, there was a paucity of evidence on 
measures to overcome structural health system barriers, such as removal of financial, geographical, 
or other barriers.  
Organised cancer screening programmes and other arrangements 
 
The inclusion criteria accepted any systematic reviews that included population-based screening in 
the population at average risk and did not differentiate between organised programmes (where 
invitations are dispatched to all those eligible, with uptake and outcomes monitored at a national or 
regional level) and other approaches, such as opportunistic screening or screening at regular health 
check-ups. However, these approaches are quite different in their mode of operation and 
effectiveness. In general, population-based organised programmes are more effective than 
opportunistic screening in obtaining higher uptake(A39, A41) and in reducing disparities in the 
access to screening(A39). Thus, we examined the extent to which they are differentiated in the 
reviews.  
Of the 90 included systematic reviews, the vast majority did not define ‘screening’ in terms of 
organised versus other screening arrangements. Only two reviews, from Italy and the UK, specified 
‘organised’ screening programmes(A3, A41). The word ‘programme’ was interpreted in various 
ways. Systematic reviews by authors from Europe tend to use it in the sense of organised 
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programmes(A36, A39, A72), although it was not always clearly defined(A38), using terms such as 
‘community’(A37, A38) ‘average risk’(A22) or ‘mass screening’(A40, A51). The type of programme 
was also not specified in an Australian review(A4). In the USA, programmes include community-
based interventions to promote uptake of screening(A56, A58, A66).  
 
Discussion 
Summary of evidence 
 
This review identified numerous barriers and facilitators to effective screening for breast, cervical 
and colorectal cancer. The literature shows that all three cancer sites have been the subject of 
studies, with no one category particularly dominating. More systematic reviews examined 
facilitators than barriers. The overall quality of the included systematic reviews was good although it 
was difficult to fully assess quality using the AMSTAR scoring mechanism given the broad range of 
review types included, particularly qualitative reviews. 
Although we were interested primarily in characteristics of health systems that impeded or 
facilitated effective screening programmes, and particularly things that could be done to improve 
the situation, it soon became clear that the literature is dominated by research on the decision by 
individuals to undergo screening. Barriers associated with characteristics of the health system were 
frequently cited, including geographical, temporal, and informational barriers. However, responses 
were largely confined to specific interventions to deal with particular problems, with little attention 
paid to health system changes that might overcome them. Such changes might include, for example, 
new ways of paying for services, reducing costs on the individual or even paying them to attend, as 
with conditional cash transfers, or new approaches to professional regulation that might support 
task shifting.  
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The majority of evidence was from the USA, where there are few organised population-based 
screening programmes, unlike in many European countries. Instead, target groups in the USA are 
mainly defined in terms of membership of a specific health insurance plan or the lack of insurance 
coverage. There was very little evidence on how health systems might promote equitable access to 
screening. We do know that organised, rather than opportunistic screening programmes are more 
effective in this respect(19, 20), but it is important to consider not just the screening process but the 
entire pathway from invitation to eventual treatment, if needed(21). Importantly, few systematic 
reviews differentiated studies undertaken within organised and opportunistic screening activities, 
although as one review has noted, even when differentiated, there is often a lack of clarity about the 
meaning of the term ‘organised’ in the context of cancer screening(22). 
Limitations 
 
This review is potentially subject to English language and other publication bias. Whilst quality and 
reporting standards were generally good, some information was missing, particularly for conference 
posters and presentations. Moreover, reporting styles varied among reviews. The scope of this 
review did not include consideration of the impact of personal or cultural beliefs. These are 
important factors that need to be explored in depth using appropriate psychological or sociological 
methods. Due to the heterogeneous and qualitative nature of much of the included evidence, 
quantitative synthesis and statistical testing was not feasible. There is insufficient space within this 
paper to fully evaluate the effectiveness of each of the interventions included in the systematic 
reviews, given the large number and diversity of studies, populations, interventions and outcomes 
evaluated. This overview did not consider the impact on equity of access or cost effectiveness of 
facilitators to screening, although his would be important in considering the sustainability of 
interventions to improve screening(20).  
Implications 
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While the present review brings together evidence on barriers to effective screening programmes, 
there is a need for much more research on the complementary activities required to maximise 
health gain, including how to ensure that the appropriate people are invited for screening, how to 
reduce opportunistic screening, and how to improve follow-up and monitoring of people once they 
have been screened.  
Conclusion  
 
Whilst many systematic reviews have been conducted on the topic of barriers and facilitators to 
cancer screening, much of the evidence is focused on the USA and on individual participation. There 
is a need for further research into barriers and facilitators from a health systems perspective, all 
along the pathway from offering screening through to follow-up interventions for those that need 
them.  
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